Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Yihong Sun, MD"'
Autor:
Jacqueline Bosch, PhD, Paul Moayyedi, MD, PhD, Marco Alings, MD, PhD, Alvaro Avezum, Jr., MD, PhD, Shrikant I. Bangdiwala, PhD, Alan Barkun, MD, CM, MSc, Federico Cassella, MD, Aloisio Marchi da Rocha, MD, PhD, Irfan Duzen, MD, Robert Enns, MD, Nauzer Forbes, MD, MSc, Leah Hamilton, MSc, Shofiqul Islam, PhD, Mustafa Kilickap, MD, MSc, Paul Kruger, MBBS, Yan Liang, MD, Jose C. Nicolau, MD, Rafael Nunes, MD, PhD, Martin O’Donnell, MD, PhD, Gustavo Oliveira, MD, PhD, Alejandro Rey, MD, Yihong Sun, MD, Thomas Vanassche, MD, Peter Verhamme, MD, Michael Walsh, MD, PhD, Zhenyu Wang, MD, Cynthia Wu, MD, Li Zhao, MD, Jun Zhu, MD, John W. Eikelboom, MBBS
Publikováno v:
CJC Open, Vol 4, Iss 11, Pp 996-1005 (2022)
Background: Bleeding is the most common adverse event in those with cardiovascular (CV) disease receiving antithrombotic therapy, and it most commonly occurs in the gastrointestinal (GI) tract. Clinicians often dismiss bleeding as an adverse event th
Externí odkaz:
https://doaj.org/article/a3549bb6b92f4bf4a92465d7fd5f018b
Autor:
Siqi Jiao MS, Ying Liu MD, Haoming He MD, Qing Li MD, Zhe Wang MD, Yinong Chen MD, Longyang Zhu MD, Shuwen Zheng MS, Furong Yang MS, Zhenguo Zhai MD, Yihong Sun MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 30 (2024)
The model for end-stage liver disease (MELD) and the model for end-stage liver disease excluding international normalized ratio (INR) (MELD-XI) scores, which reflect dysfunction of liver and kidneys, have been reported to be related to the prognosis
Externí odkaz:
https://doaj.org/article/8efea0204e9043a58c48a496e4233c6d